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Abstract
Influenza A virus (IAV) is a leading cause of respiratory tract disease worldwide. Anti-viral CD8+ T lymphocytes responding to
IAV infection are believed to eliminate virally infected cells by direct cytolysis but may also contribute to pulmonary
inflammation and tissue damage via the release of pro-inflammatory mediators following recognition of viral antigen
displaying cells. We have previously demonstrated that IAV antigen expressing inflammatory cells of hematopoietic origin
within the infected lung interstitium serve as antigen presenting cells (APC) for infiltrating effector CD8+ T lymphocytes;
however, the spectrum of inflammatory cell types capable of serving as APC was not determined. Here, we demonstrate
that viral antigen displaying neutrophils infiltrating the IAV infected lungs are an important cell type capable of acting as
APC for effector CD8+ T lymphocytes in the infected lungs and that neutrophils expressing viral antigen as a result of direct
infection by IAV exhibit the most potent APC activity. Our findings suggest that in addition to their suggested role in
induction of the innate immune responses to IAV, virus clearance, and the development of pulmonary injury, neutrophils
can serve as APCs to anti-viral effector CD8+ T cells within the infected lung interstitium.
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Introduction
Influenza A virus (IAV) is a major cause of severe respiratory
viral infections, particularly among the elderly and very young
children and can exacerbate pre-existing conditions such as
cardiovascular disease [1]. Epithelial cells of the upper and lower
respiratory tract are critical for virus propagation as these cells
possess a key host protease essential for proper maturation of the
viral hemagglutinin receptor and as a result, supports productive
infection of the virus. While other cell types (e.g. fibroblasts and
cells of hematopoietic origin) can take up IAV virions and support
de novo viral gene expression [2,3], in most instances (and for most
IAV strains), these infected non-epithelial cell types do not support
the production of fully infectious virions. Due to this cellular
restriction in viral propagation, IAV-infected respiratory epithelial
cells represent critical cellular targets of the host response to IAV
infection
Cells of both the innate and adaptive immune system play
important roles in the host response IAV infection including the
control and elimination of infectious virus and the induction of
inflammation and tissue injury associated with virus infection and
virus elimination. In the IAV infected murine lungs, effector CD8+
T cells primarily control infection and eliminate virally infected
cells by direct cytolysis of these infected cells, most notably infected
respiratory epithelial cells [4,5,6]. These effector CD8+ T cells in
infected lungs also produce cytokines/chemokines, which may
contribute to but are not essential for ultimate virus clearance
[7,8,9,10,11].
Our laboratory has recently demonstrated that in the IAV
infected lungs, the cell type recognized by the anti-viral CD8+ T
cells dictates the spectrum of effector activity [5]. The respiratory
epithelium, the cell type supporting productive viral infection,
triggered cytolysis by effector CD8+ T cells but does not stimulate
T cell cytokine production. In contrast, inflammatory cells
infiltrating the IAV infected lungs are potent stimulators both of
cytolysis and cytokine production by the effector CD8+ T cells. We
further observed that cytokine production by the effector T cells
also required specific IAV antigen recognition and was dependent
on expression of co-stimulatory ligands (e.g. CD80 and CD86). We
also demonstrated that CD11chi macrophages and dendritic cells
infiltrating the IAV infected lungs were potent APC for cytokine
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production by effector CD8+ T cells. The contribution of any
other inflammatory cell type(s) infiltrating the IAV infected lungs
as potential APC for effector CD8+ T cells was not assessed.
Neutrophils are a prominent component of the inflammatory
cell infiltrate accumulating in the IAV infected lungs [12,13,14].
Neutrophils have been reported both to facilitate (or indeed even
mediate) virus clearance and to modulate pulmonary inflamma-
tion and injury associated with the host response to infection
[7,8,9,10,11]. What role, if any, neutrophils play as APC for IAV
specific effector CD8+ T cells in the infected lungs is at present
unknown. Likewise, the susceptibility of neutrophils recruited to
the respiratory tract to infection by IAV and the requirement for
direct infection of neutrophils for this cell type to serve as an APC
in the IAV infected lungs have been largely unexplored to date.
In this report, we evaluated the capacity of immune/inflam-
matory cells in the IAV infected lungs to take up IAV antigens, the
susceptibility of lung infiltrating neutrophils to IAV infection, and
the ability of neutrophils to serve as APC for effector CD8+ T cells
in the infected lungs. We demonstrate that a significant fraction of
these lung infiltrating neutrophils are infected by IAV as measured
by de novo viral gene expression and protein display in these
neutrophils. We further demonstrate that viral antigen displaying
neutrophils isolated from the IAV infected lungs could act as APC
and stimulate cytokine production by effector CD8+ T cells
isolated from the IAV infected lungs with infected neutrophils
exhibiting the most potent APC activity. Consistent with these
results, we found that acute in vivo depletion of neutrophils
significantly reduced soluble mediator production by effector
CD8+ T cells. Together, these results suggest that neutrophils
infiltrating the IAV infected lungs may be potent APC for anti-
viral CD8+ T cell in the IAV infected lungs.
Results
Kinetics of accumulation of innate and adaptive immune
cells in the lungs following influenza infection
Inflammatory cells representative of both the innate and
adaptive immune system accumulate over time in the infected
lung interstitium in response to IAV infection. Kinetic analysis of
the accumulation of mononuclear and granulocytic innate
immune cells in the lungs following sub-lethal infection of mice
with the mouse-adapted IAV strain, A/Puerto Rico/8/34 (PR8)
revealed that inflammatory mononuclear cells of the dendritic cell
(DC)/macrophage lineage (so called exudate macrophages, TNF
iNOS-producing DCs [15,16]; CD45+, Ly6Chi, Ly6G2, CD11bhi,
CD11chi) were the most prominent innate immune cell type
identified with maximum accumulation occurring approximately
10–12 days post infection (dpi) (Figure 1A and see Figure S1 for
gating strategy). Neutrophils (CD45+, Ly6Cint, Ly6Ghi, CD11bhi)
were likewise prominently represented in the inflammatory
infiltrate (Figure 1A and Figure S1). As expected, neutrophils
were first detected prior to the influx of inflammatory mononu-
clear cells (i.e. 2 dpi), peaked at 5–6 dpi, and decreased in number
gradually following the resolution of infection (Figure 1A).
T lymphocytes (FSClo, SSClo, CD45+, Thy+, TCRb+) were the
dominant lymphocytic cell subset infiltrating the lungs during
influenza infection. T lymphocytes reached similar numbers and
exhibited similar kinetics of peak accumulation (i.e. 10–12 dpi)
(Figure 1B) as inflammatory mononuclear cells (Figure 1A).
Influenza antigen (ag)-specific effector CD8+ T cells accumulated
with a similar kinetics as total T lymphocytes with the notable
exception that the ag-specific CD8+ T cells were first detected
between 4–6 dpi, that is, following their generation in and
subsequent egress from the draining lymph nodes (DLNs)
(Figure 1C). This early influx of ag-specific CD8+ T cells into
the lung interstitium was associated with the release of the
signature effector T cell cytokine, IFNc, into the infected lungs as
detected in bronchoalveolar lavage (BAL) fluid (Figure 1D). The
early influx of effector T cells from the DLN into the infected lungs
and the production of effector cytokines likewise paralleled the
kinetics of virus elimination from the infected lungs (Figure 1E).
Two other lymphocytic cell subsets, B cells (FSClo,SSClo, CD45+,
B220+, TCRb2) and NK cells (FSClo, SSClo, CD45+, B2202,
TCRb2; Dx5+), accumulated in substantial numbers in the
infected lung interstitium with the tempo comparable to that of
infiltrating T lymphocytes (Figure 1B).
Influenza antigen expression by lung infiltrating CD45+
cells
Although virus clearance from the infected respiratory tract and
specific elimination of infected respiratory epithelial cells is critical
for control of influenza infection and recovery [4,5,6], we recently
reported that effector cytokine production by anti-viral CD8+ T
cells in the influenza-infected lungs is triggered not by the infected
respiratory epithelium but rather by CD45+ inflammatory cells
infiltrating the infected lungs [5]. It was therefore of interest to
assess the kinetics and level of expression of influenza nucleocapsid
protein (NP) by these lung infiltrating inflammatory cells since NP
is the most abundant prototypical influenza antigen within the
cytoplasm and nucleus of the IAV infected cell and is a major
target of ag-specific effector CD8+ T cells. We prepared lung cell
suspensions from infected lungs at various dpi. We fixed and
permeabilized cells following cell surface marker staining and
probed the permeabilized cells for the expression of intracellular
NP using a flow cytometry based analysis.
As Figure 2A demonstrates, the inflammatory mononuclear
cells were the dominant NP bearing cell population in the infected
lungs, with maximum accumulation of NP+ inflammatory
mononuclear cells (,10–30% of lung infiltrating mononuclear
cells) at peak virus replication (i.e. 4 dpi) (Figure 1E). Furthermore,
the number of NP+ inflammatory mononuclear cells decreased
(Figure 2A) as infectious virus was eliminated from the infected
lungs (Figure 1E). We also observed a significant fraction (,5–
15%) of lung infiltrating granulocytic cells with the phenotypic
characteristics of neutrophils (i.e. Ly6Ghi, CD11bhi) expressing NP
protein (Figure 2A). NP+ granulocytes were enumerated over time
using granulocytes from the lungs of mice infected with type B
influenza strain B/Lee as the gating control (Figure 2B) The tempo
of NP expression by neutrophils was comparable to that of
infiltrating inflammatory mononuclear cells and followed the
kinetics of influenza replication and clearance in the infected lungs
(Figure 1E). The expression of NP was not a feature of all
inflammatory cells infiltrating the infected lungs. Only a small
fraction of lung infiltrating B lymphocytes (,1–2%) were NP
positive and even smaller numbers of NK and T cells expressed
this antigen (,1–2%) (Figure 2C), though the latter cell type was
the major lymphocyte population infiltrating the infected lungs
(Figure 1B).
Neutrophils are infected by influenza virus
Unlike most RNA viruses, the replication of the influenza
genome occurs within the nucleus of the virally-infected cell [17].
Since mature circulating neutrophils are short lived and display
condensed chromatin, features typical of cells with minimal gene
expression [18], it seemed most likely that neutrophils infiltrating
the infected lungs would display influenza NP because these cells
had taken up NP present in virus or dead/dying infected cells in
the lungs. To further establish that the cells identified were
Neutrophils Serve as APCs during IAV Infection
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neutrophils, we sorted the CD45+, Ly6Cint, Ly6Ghi, CD11bhi cell
subset (Figure 3A) and examined the cells for granulocytic
morphology. As Figure 3B demonstrates, the Ly6Ghi, CD11bhi
cell subset had the characteristic morphology of neutrophils.
Since, as noted above, uptake of NP from dead/dying infected
cells or influenza virions was the most likely explanation for NP
expression by lung infiltrating neutrophils, it was of interest to
determine if viral antigen expression was due to the ability of the
cells to be infected by IAV. We reasoned that phagocytic uptake of
infected dying cells or virus would localize influenza proteins such
as NP and presumably type A virus hemagglutinin (HA) to an
intracellular endosomal compartment. By contrast following
infection, the influenza NP would remain intracellular (i.e.
requiring cell permeabilization to detect the cytoplasmic/nuclear
NP by flow cytometry), but the newly synthesized HA glycoprotein
would be detectable on the cell surface prior to fixation and
permeabilization. We carried out this flow-based analysis on
neutrophils isolated at the peak of PR8 infection and found that
,10% of NP+ neutrophils simultaneously expressed the viral HA
on their surface (Figure 3C). Importantly, while we could detect
HA2NP+ neutrophils, we were unable to detect any cells
expressing HA exclusively (HA+NP2). The specificity of this
detection strategy was verified by the failure of these antibodies to
detect type A influenza proteins in neutrophils taken from mice
infected with the influenza B/Lee strain (Figure 3C).
To further establish that the lung infiltrating neutrophils were
infected by IAV, we analyzed RNA from sorted HA+ and HA2
neutrophils for expression of the spliced mRNA encoding the
influenza M2 gene production which is only present within
infected cells. As Figure 3D demonstrates, we detected M2 gene
expression primarily (but not exclusively) in the sorted HA+ lung
neutrophils thereby establishing the capacity of mature tissue
infiltrating neutrophils exposed to influenza to support de novo
influenza virus gene expression.
To complement and support these findings, we next utilized a
reverse genetics engineered PR8 strain which expresses the GFP
gene within the influenza non-structural (NS) gene, in such a way
as to not disrupt NS gene expression [3]. Because the NS-encoded
GFP protein is not incorporated into the virion itself but is only
expressed within virally-infected cells, we could use GFP protein
expression during NS-GFP virus infection in vivo to identify
infected cells (i.e cells undergoing de novo influenza protein
synthesis). Following NS-GFP virus infection of C57BL/6 mice,
we detected GFP expression in approximately 10% of the
neutrophil subset (Ly6Ghi, CD11bhi) (Figure 4A). Similar results
were seen in BALB/c mice (Figure 4C). Hematopoietic cells from
mice infected with the wt influenza virus demonstrated a modest
level of fluorescence in the GFP channel (most likely representing
background fluorescence), but this was not associated with the
neutrophil subset (Figure 4B). As expected, surface expression of
HA on neutrophils was associated only with GFP+ cells (Figure 4C)
while a somewhat larger fraction of GFP2 cells (i.e. 20%)
expressed intracellular influenza NP antigen (data not shown).
Neutrophils serve as APC for influenza-specific effector
CD8+ T cells
The above results demonstrated that neutrophils could support
de novo IAV gene expression in vivo within the infected lungs and
Figure 1. Host immune response to influenza infection. (A–E) BALB/c mice were infected with PR8 (0.1LD50) i.n. (A) Absolute numbers of
neutrophils (solid line) and inflammatory mononuclear cells (dashed line) infiltrating the respiratory tract over time. (B) Absolute numbers of
lymphocytes (T cells – gray dashes; B cells – black dashes; NK cells – solid lines) infiltrating the respiratory tract over time. (C) The number of lung
antigen-specific CD8+ T cells was estimated following in vitro re-stimulation with influenza-infected target cells (P815) and analysis of IFNc+CD8+ T
cells via flow cytometry. (D) IFNc content and (E) viral titer in sampled BAL fluid over time. Dashed line signifies limit of viral detection. (A–E) Two-
three independent experiments (n = 2–4/expt) represented as mean 6 SEM.
doi:10.1371/journal.pone.0046581.g001
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that both the infected (HA+NP+GFP+) neutrophils as well as the
presumably uninfected (HA2NP+GFP2) NP antigen containing
neutrophils were present at the peak of CD8+ T cell effector
activity. In view of these findings, we asked whether these lung-
infiltrating neutrophil populations could act as APC for IAV-
specific effector CD8+ T cells. We have previously demonstrated
that the triggering of cytokine production by effector CD8+ T cells
in the infected respiratory tract requires TCR engagement of
MHC Class I/IAV antigen complexes as well as interaction with
co-stimulatory ligands, notably CD80 and CD86 [5]. As depicted
in Figure 5A, neutrophils isolated from the infected lung indeed
expressed equivalent levels of MHC I as inflammatory mononu-
clear cells and express CD80 and CD86, at only slightly lower
levels. In contrast, neutrophils did not express MHC Class II,
which is necessary for CD4+ T cell recognition of antigen.
To evaluate the in vitro APC activity of neutrophils exposed to
IAV in vivo, we purified by cell sorting GFP+ (infected) and GFP2
(uninfected) neutrophils from the lungs of mice infected with the
NS-GFP virus. In order to ensure that the in vitro interaction of
lung derived neutrophils with effector T cells as closely as possible
mimicked the interaction in vivo, we used as a defined source of
effector CD8+ T cells for in vitro co-culture with neutrophils, PR8
(HA533–41 epitope) specific CD8
+ TCR transgenic (tg) clone 4 (Cl-
4) T cells isolated from PR8 infected lungs 8 days after adoptive
transfer and virus infection. Thus, both the neutrophils and the
effector CD8+ T cells employed in this in vitro analysis were isolated
from the infected lungs. Infected (GFP+) neutrophils had potent
APC activity as reflected through IFNc production by Cl-4 T cells
in the in vitro intracellular cytokine staining (ICCS) assay, at T
cell:APC ratios as low as 1:1 (Figure 5B). It is noteworthy that the
frequency of IFNc+ T cells stimulated by the infected neutrophils
was comparable to that of un-infected neutrophils pulsed with the
synthetic HA533–41 peptide epitope recognized by Cl-4 T cells. By
contrast, un-infected (GFP2) neutrophils co-cultured with Cl-4 T
cells at a comparable ratio exhibited weaker APC activity than
infected cells (i.e. frequency and MFI of Cl-4 IFNc production;
Figure 5C). However, while not as potent APC as infected
neutrophils, GFP2 neutrophils were capable of triggering the IAV
HA-specific Cl-4 T cells when the cells were co cultured at higher
T cell:neutrophil ratios.
The above in vitro findings supported the possibility that like
inflammatory mononuclear cells present in the lungs of influenza-
infected mice [5], neutrophils may also serve as APC for lung
infiltrating effector CD8+ T cells in vivo. To directly address this
possibility we examined the impact of acute antibody mediated
(aLy6G) in vivo depletion of neutrophils from infected mice at 5 dpi
on effector (i.e. IFNc) cytokine production by CD8+ T cells
24 hours later. Acute administration of the Ly6G depleting
antibody reduced neutrophil numbers by 90% 24 hours later
(i.e. 6 dpi), which is also the peak of CD8+ T cell cytokine
production (Figure 6A and 6B). Importantly, acute neutrophil
depletion at 5 dpi had no effect either on lung virus titer (data not
shown), the frequency of inflammatory mononuclear cells, or the
frequency of IAV specific effector CD8+ T cells in the infected
lungs (as measured by the in vitro ICCS assay) (Figure 6C and 6D).
Neutrophil depletion did result in a substantial decrease in IFNc
release into the bronchoalveolar lavage (BAL) fluid 24 hours later
(i.e. 6 dpi) compared to isotype antibody-treated infected mice
(Figure 6E). IL-10, the regulatory cytokine which is primarily
produced by effector CD8+ T cells during IAV infection [19], was
also diminished in neutrophil depleted mice compared to controls,
though this was variable from experiment to experiment (data not
shown).
Although our laboratory has previously reported that IFNc
released into the BAL fluid is principally T cell-derived during
influenza infection [5,19], we wanted to further ensure that the
Figure 2. Hematopoietic cell influenza nucleocapsid protein content during an influenza virus infection. (A–C) BALB/c mice were
infected with PR8 (0.1LD50) i.n.. (A) Absolute numbers of NP
+ neutrophils (solid line) and NP+ inflammatory mononuclear cells (dashed line) infiltrating
the respiratory tract over time. (B) Representative flow cytometry panels depicting influenza NP expression in the lung neutrophil population during
the course of an influenza virus infection. Neutrophils from PR8 (top panels) or B/Lee (bottom panels) infected mice are depicted. (C) Absolute
numbers of NP+ lymphocytes (T cells – gray dashes; B cells – black dashes; NK cells – solid lines) infiltrating the respiratory tract over time. (A–C) Cells
from B/Lee infected mice (at corresponding day p.i.) were utilized to set flow cytometric gate due to the inability of the aNP to recognize B/Lee NP.
Two independent experiments (n = 2–4/expt) represented as mean 6 SEM where applicable.
doi:10.1371/journal.pone.0046581.g002
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reduction in mediators release following acute neutrophils
depletion was due to the impact of the elimination of this cell
type on the function of CD8+ T cells in vivo. To identify T cells
actively producing IFNc in vivo, we employed a modified form of
the in vivo ICCS assay [5,20], where the protein transport inhibitor
monensin is administered into infected mice to prevent T cell
cytokine release. When T cells producing IFNc in vivo were
enumerated using this assay, we found, consistent with the
cytokine release data from the BAL fluid, that there was a
statistically significant decrease in the numbers of CD8+ T cells
secreting IFNc (IFNc+CD8+ T cells) in vivo compared to the
corresponding isotype controls (Figure 6F). Neutrophil depletion
only affected CD8+ T cell IFNc production in vivo as the absence of
neutrophils had no apparent impact on the migration, accumu-
lation, or frequency of ag-specific CD8+ T cells into/within the
infected respiratory tract (Figure 6D). Importantly, the acute
neutrophils depletion had no effect on IFNc producing CD4+ T
cells (Figure 6G) consistent with the fact that neutrophils express
no MHC Class II and would not be expected to serve as APCs for
anti-viral effector CD4+ T cells in vivo (Figure 5A). Thus, while
acute neutrophil depletion has no effect on the frequency of
antigen specific CD8+ T cells trafficking to the infected lungs
during the 24 hours following depletion, the elimination of
neutrophil APC activity did diminish the efficiency of mediator
release by the effector CD8+ T cells
Discussion
In this study, we characterized the response of neutrophils
infiltrating the lungs following IAV infection. We observed that
neutrophils and inflammatory mononuclear cells were the most
abundant myeloid lineage cells present in the infected lungs at the
peak of CD8+ T cell effector activity (i.e. day 6 p.i.) when cytokine
production by effector CD8+ T cell was maximal. Although the
lymphoid lineage cells were also present in large numbers in the
IAV infected lungs at this time, only neutrophils and inflammatory
mononuclear cells contained intracellular deposits of the IAV
nucleocapsid protein (i.e. NP+ cells) in significant numbers. Among
the NP+ neutrophils, up to 10% were shown to be infected as they
simultaneously expressed both intracellular NP and cell surface
HA. This is probably an underestimate of the true frequency of
infected neutrophils if the tempo of NP and HA protein expression
in the infected neutrophils differ (i.e. NP expression early post
infection and HA expression later). In support of the infected
status of the NP+HA+ lung neutrophils, the cells were substantially
enriched for expression of the spliced M2 mRNA compared to
NP+HA2 neutrophils. We further confirmed that neutrophils
infiltrating the IAV infected lungs were susceptible to infection (de
novo viral gene expression) using the GFP reporter recombinant
IAV strain. Employing GFP expression as an indicator of IAV
infection of neutrophils, we separated GFP+ and GFP2 neutro-
phils from the infected lungs and demonstrated that GFP+
neutrophils were potent in vitro stimulators of cytokine production
by effector CD8+ T cells isolated from the IAV infected lungs. We
further demonstrated that acute elimination of neutrophils in vivo
significantly reduced total effector cytokine release in the infected
lungs and diminished the frequency of IFNc secreting effector
CD8+ T cells in vivo without altering effector CD4+ T cell responses
to IAV in the infected lungs.
Figure 3. De novo influenza mRNA expression in lung
neutrophils. (A–D) BALB/c mice were infected with PR8 (10LD50)
i.n.. Cells were collected from 4 dpi animals (A) BAL fluid flow profile of
percent of neutrophils (Ly6G+CD11bhi). Cells gated previously as
CD45+Thy1.22. (B) DiffQuick staining of sorted neutrophils
(CD45+Ly6G+ Ly6CintCD11bhi) (C) Representative flow profile of HA+NP+
neutrophils at 4 dpi (Cells gated as CD45+Thy1.22Ly6G+CD11bhi). B/Lee
infected mice were utilized to set flow cytometric gate. (D) Influenza M2
mRNA expression (relative to GAPDH) from sorted HA+ and HA2
neutrophils (CD45+Ly6G+ Ly6CintCD11bhi). Table is representative of one
experiment. Additional experiment yielded similar results. (A–D) Two
independent experiments (n = 2–4/expt) represented as mean 6 SEM
(where applicable).
doi:10.1371/journal.pone.0046581.g003
Figure 4. De novo influenza protein expression in lung
neutrophils. (A–B) C57BL/6 mice were infected with NS-GFP or PR8
(10LD50) influenza virus. At 5 dpi, total lungs were collected.
Representative flow profile of (A) total lung neutrophil GFP expression
and (B) the percent of neutrophils present of total GFP+ hematopoietic
cells. (A–B) Two independent experiments (n = 3–4/expt). (C) BALB/c
mice were infected with NS-GFP influenza virus. At 5 dpi, total lung was
collected. Representative flow profile GFP+ and GFP2 neutrophil HA
staining. Two independent experiments (n = 2/expt). (A–C) Neutrophils
gated as CD45+Ly6G+CD11bhi. GFP gate was set utilizing splenic cells
from infected animals. HA gate was set utilizing isotype control.
doi:10.1371/journal.pone.0046581.g004
Neutrophils Serve as APCs during IAV Infection
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The finding that a small but nevertheless substantial fraction of
the neutrophils infiltrating the infected lungs are susceptible to
influenza infection was not anticipated. Mature neutrophils are
short lived within the respiratory tract [21], contain a high ratio of
heterochromatin to euchromatin [18,22], and are generally
considered to be largely transcriptionally inactive [21]. These
properties of neutrophils suggest a cellular environment which
would be non-permissive for an RNA virus like IAV, whose
genome replicates in the nucleus and is dependent on nuclear
localized host factors [12,17]. In support of this concept, bone
marrow (BM)-derived neutrophils were recently shown to be
resistant to influenza infection in vitro [23]. However, during
phagocytosis, neutrophils do undergo active transcription and can
be demonstrated to up-regulate transcriptional activity in response
to bacterial and viral infections [21], which may allow this cell type
to support infection (i.e. de novo gene expression, following infection
by certain organisms). Indeed, neutrophils have been shown to
support infection by intracellular bacteria [21], herpes viruses
[24,25], and most recently, the engineered NS-GFP reporter IAV
strain [3]. The failure to detect infection of neutrophils by IAV in
previous reports may be due to underappreciated differences in the
activation state (e.g. transcriptional activity) between neutrophils
isolated from the bone marrow or circulation with subsequent
infection in vitro [12,23] and tissue infiltrating neutrophils exposed
to IAV in situ [3]. In this connection, it is important to note the
likelihood of species dependent differences in susceptibility of
neutrophils to infection since circulating human neutrophils may
be susceptible to infection by IAV (i.e. able to take up the virus
when exposed to IAV ex vivo and allow expression of IAV genes in
short-term culture) [26,27,28]. Furthermore in at least one report
of lethal human infection with highly pathogenic avian H5N1
IAV, neutrophils were shown to contain IAV protein and RNA.
However whether this was due to direct infection or uptake of
virus/infected cellular material was not determined [28].
The expression of the virus GFP reporter gene in neutrophils,
the detection of cell surface HA, and the presence of elevated levels
of spliced viral M2 mRNA in the HA+GFP+ neutrophils represent
rigorous criteria that neutrophils are infected by IAV in vivo.
Figure 5. Neutrophils can stimulate CD8+ T cell pro-inflammatory cytokine production in vitro. (A) BALB/c mice were infected with PR8
(0.1LD50) and lungs were collected at 6 dpi. Inflammatory mononuclear cells (dashed lines) and neutrophil (solid line) MHC and co-stimulatory
molecule expression is depicted. Isotype control is shaded area. Two independent experiments (n = 2–4/expt). (B–C) BALB/c mice were infected with
NS-GFP influenza virus. At 5 dpi, lung neutrophils (CD45+, Thy2, Ly6Ghi, Ly6Cint, CD11bhi) were sorted based on GFP expression. In parallel, 26105 CL-
4 CD8+Thy1.1+ were adoptively transferred into Thy1.2+ BALB/c mice and were infected with PR8 (0.1LD50) the following day. At 8 dpi, lung CL-4 cells
(CD45+, Thy1.22, Thy1.1+CD42,CD8+) were sorted and cultured (B) in a 1:1 ratio with GFP+ neutrophils or (C) in depicted effector:target ratios with
GFP2 neutrophils. (B–C) Cells were co-cultured for six hours in the presence of GolgiStop. Representative flow profiles depict CL-4 T cell (CD45+CD8+
Thy1.1+ FSCloSSClo) IFNc production. HA533–41 pulsed CL-4 T cells served as a positive control. Mean fluorescence intensity (MFI) is depicted with
standard deviation. Two independent experiments (n = 2/expt).
doi:10.1371/journal.pone.0046581.g005
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Infected neutrophils serve as potent APC for effector CD8+ T cells
in short term in vitro culture. The likely explanation for their
potency is that direct infection provides the most efficient
mechanism to generate and load processed viral peptides onto
MHC I molecules. Although we detect minimal differences in the
expression of MHC I molecules and conventional accessory
molecules (e.g. co-stimulatory ligands CD80/86) between GFP+
and GFP2 neutrophils (data not shown), we cannot formally
exclude the possibility of an infection induced alteration in
expression of cell surface or soluble molecules in the infected cells
which accounts for efficient triggering of effector CD8+ T cells. We
also observed that only approximately 50% of infected/GFP+
neutrophils were simultaneously HA+/hi. While this could reflect a
failure to express the full complement of IAV genes in this cell
type, a more likely explanation, as noted above, is that viral gene
expression is not coordinated (i.e. NS gene expression proceeds at
a faster rate than HA).
Uninfected (GFP2HA2) neutrophils included both NP+ and
NP2 cells. This cell population could also serve as APC for effector
CD8+ T cells in vitro suggesting that within this neutrophil
population were cells displaying the processed HA epitope
recognized by the TCR tg CL-4 T cells. The likeliest explanation
for the capacity of these cells to stimulate effector CD8+ T cells is
that the neutrophils in the infected lungs have taken up IAV
antigens (e.g. HA) derived from virions and/or infected cell
remnants and cross presented processed viral antigen to the T
cells. To our knowledge, this is the first demonstration in the
murine system (following natural infection) of processing and cross
presentation of viral antigens to CD8 T cells although murine
neutrophils have previously been reported to cross present soluble
antigen in vivo and bacterial antigen in vitro to CD8+ T cells [29,30].
We cannot formally evaluate if antigen-presenting activity is
restricted to the NP+ subset of uninfected neutrophils since
detection of the intracellular NP requires permeabilization of the
cells (with loss of viability) prior to cell sorting. If only a fraction of
the uninfected neutrophils (i.e. the NP+ cells) display the relevant
peptide MHC complex, this could in part account for the lower
efficiency of effector CD8 T cells stimulation by the uninfected
(GFP2) neutrophil subset.
We and others have previously identified CD11chi inflamma-
tory mononuclear cells as stimulators of CD8+ T cell effector
activity in vivo [5,31,32]. Our findings both in vitro and in vivo
implicate neutrophils as a second inflammatory cell type capable
of acting as a potent APC for effector CD8+ T cells during the
adaptive immune response to IAV in the lungs. Our observation
that acute depletion of neutrophils in vivo significantly diminished
the release of IFNc by effector CD8+ T cells in the lungs strongly
supports this view. We had also noted in the infected lungs of mice
depleted of neutrophils an apparent, but not statistically signifi-
cant, reduction in the release into the BAL fluid of the regulatory
cytokine IL-10 (data not shown), which we have previously
identified as a major CD8+ T cell product during IAV infection
[19,33]. The significance of this difference in the impact of
neutrophil depletion on IFNc and IL-10 production by effector
CD8+ T cells in the lungs is currently unclear and will require
further investigation. Other T cell derived cytokines were modestly
affected by acute neutrophil depletion, as well (e.g. MIP-1a; data
not shown); however, many infiltrating immune cell types as well
as resident lung cells produce these cytokines complicating the
interpretation of the results. It is formally possible that neutrophils
Figure 6. Neutrophils trigger CD8+, but not CD4+, T cell anti-viral activity in vivo. (A–G) BALB/c mice were infected with PR8 (0.1LD50) and
at 5 dpi, were administered 500 ug isotype or aLy6G depleting antibody i.p.. Lung tissue/BAL fluid was collected twenty-four hours later. (A)
Representative flow profile depicting neutrophil depletion (previously gated as CD45+Thy1.22). Absolute number of lung (B) neutrophils, (C)
inflammatory mononuclear cells, and (D) antigen-specific CD8+ T cells in isotype or depleting antibody treated mice. (B) Neutrophils were gated as
CD45+, GR1hi, CD11bhi, FSClo, SSCint and (C) inflammatory mononuclear cells as CD45+, Ly6Chi, GR1int/lo, CD11bhi,MHC IIhi. (D) Antigen-specific CD8+ T
cells was estimated following in vitro re-stimulation with influenza-infected target cells (P815) and analysis of IFNc+CD8+ T cells via flow cytometry. (E)
IFNc content in sample BAL fluid. (F–G) Six hours prior to harvest, monensin was administred i.p. to mice (in vivo ICCS assay). The number of (F) CD8+
or (G) CD4+ T cells producing IFNc with and without neutrophil depletion is depicted. (A–D) Three independent experiments (n = 2–3/expt)
represented as mean 6 SEM (where applicable). Considered statically significant at P,.05 (*).
doi:10.1371/journal.pone.0046581.g006
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function indirectly to support or enhance the soluble mediator
response of CD8 T cells by recruiting, activating, and/or serving
as a IAV antigen reservoir for MHC class I and II+ CD11chi
inflammatory mononuclear cells [30,34,35,36,37]. Because of the
minimal impact of the acute neutrophil depletion in vivo on CD4+
T cell derived IFNc production, we favor a direct role of
neutrophils as APC for CD8+ T cells. Thus, we conclude
neutrophils, as well as CD11chi inflammatory mononuclear cells,
are key APCs regulating the pro-inflammatory and regulatory
cytokine production by effector CD8+ T cells in the IAV-infected
lung in vivo.
In conclusion in this report, we demonstrate that neutrophils are
capable of both being infected by IAV and acquiring viral antigen
by phagocytosis of infectious virus or infected cells. Neutrophils
and in particular infected neutrophils act as potent APC to trigger
the release of soluble mediators by effector CD8+ T cells
responding in the infected lungs to IAV infection. It remains to
be determined whether there is a virus strain dependent difference
in the susceptibility of neutrophils infiltrating the infected lungs to
IAV infection and whether infection of neutrophils by IAV in
lungs impacts on the pathogenesis of IAV infection and the innate
and adaptive immune response to infection.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the Animal
Welfare Act (Public Law 91-579) and the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health (OLAW/NIH, 2002). All animal experiments
were performed in accordance with protocols approved by the
University of Virginia Animal Care and Use Committee (ACUC;
Protocol Number 2230).
Mice and infection
Female BALB/c, C57BL/6, and Thy-1.1 CL-4 tg mice (BALB/
c background) were purchased from the National Cancer Institute
and Jackson Laboratories. All mice were housed in a pathogen-
free environment and used at 8–14 weeks of age for all
experiments. NS-GFP virus was a generous gift from the Adolfo
Garcia-Sastre laboratory [3]. Type A influenza viruses PR8
(H1N1), NS-GFP (H1N1), and type B influenza B/Lee were
grown in day 10 chicken embryo allantoic cavities as described
previously [38]. Mice were infected with 250 EID PR8 (0.1LD50),
25,000 EID PR8 (10LD50), 10
5 EID NS-GFP, or 105 EID B/Lee.
All infectious doses were administered i.n. in 50 mL (diluted in
serum-free Iscove’s medium (Invitrogen)) following ketamine and
xylazine anesthesia.
Tissue preparation
Mice were euthanized via cervical dislocation. Lungs were
perfused via the right ventricle of the heart with PBS and were
enzymatically digested with Type II collagenase (37uC for
30 minutes; Worthington), followed by passing through a steel
screen. Red blood cells in the cell suspensions were lysed using
ammonium chloride. Cells were counted using a hemacytometer
after Trypan blue dye exclusion and resuspended in FACS buffer
containing PBS, 2% FBS, 10 mM EDTA, and 0.01% sodium
azide for Ab staining or MACS buffer containing PBS, 2% FBS,
and 10 mM EDTA for sorting.
Antibodies
The following monoclonal antibodies (mAb) were purchased
from BD-Biosciences (BD; San Diego, CA) or eBiosciences (eBio;
San Diego, CA)(unless stated), as conjugated to FITC, Alexa-488,
PE, PE-Cy7, PerCP-Cy5.5, APC, Alexa-647, APC-Alexa780 or
Biotin: CD4 (GK1.5), CD8a (53-6.7), CD11b (M1/70), CD11c
(HL3), CD45 (30-F11), CD80 (16-10A1), CD86 (GL-1), CD90.1
(OX-7), CD90.2 (53-2.1), Gr-1 (RB6-8C5), Ly6G (1A8), Ly6C
(AL-21), H-2Kb (AF6-88.5), H-2Kd (SF1-1.1), I-Ad (AMS-32-1),
IFNc (XMG1.2), and HA (Kind gift from Dr. Jon Yewdell, NIH/
NIAID), isotype control antibodies. Anti-mouse CD16/32 and
influenza NP (HB65) was isolated and purified in our laboratory.
For biotinylated mABs, samples were incubated with streptavidin-
PE.
In vitro CD8+ T cell re-stimulation assay
To measure IFNc stimulation, CD8+ T cells were co-cultured
cells for 6 hours at 37uC in DMEM+5% FCS in the presence of
Golgi-Stop (BD Biosciences, 1.6 mL mL21). For identification of
antigen-specific polyclonal CD8+ T cells, single-cell suspensions
from BALB/c mice were co-cultured with infectious virus-pulsed
P815 cells (10 MOI) in a 1:1 ratio. The percent of CD8+ T cells
stimulated to produce IFNc as determined by flow cytometry was
utilized to calculate total number of antigen-specific CD8+ T cells.
Flow cytometry staining, analysis, and sorting
Cells suspensions were blocked with anti-mouse CD16/32 and
then incubated with specific mAbs or isotype/FMO controls for
30 min at 4uC. Surface maker staining and intracellular cytokine
staining were described previously [39]. Flow Cytometry was
performed on FACS Canto flow cytometers (BD), and data were
analyzed using FlowJo (Tree Star, Inc.). Neutrophils and T cells
were sorted following MACS enrichment (Thy1.2 negative
selection for neutrophils, CD8 positive selection for T cells) using
a FACS Vantage SE Turbo sorter at the Flow Cytometry Core
Facility (University of Virginia). Purity of neutrophils was
confirmed by DiffQuick staining (IMEM Inc.) as per manufactur-
ers’ instructions.
Flow cytometric detection of influenza-infected cells
types
Cells suspensions were blocked with anti-mouse CD16/32 and
then incubated with specific surface mAbs and HA antibody
conjugated to biotin (Kind gift from Dr. Jon Yewdell, NIH/
NIAID) for 30 min at 4uC. Cells were washed and then incubated
with streptavidin-PE for ten minutes at 4uC. Cells were washed
and were resuspended in Cytofix/Cytoperm solution (BD)
according to the manufacturer’s protocol. Cells were washed with
PermWash (BD), and intracellular stained with NP antibody
conjugated to Alexa-647 for thirty minutes at 4uC. Cell
suspensions from B/Lee infected mice at equivalent days post
infection were utilized to set flow cytometry gates.
Bronchoalveolar lavage fluid (cytokine and viral titer)
We obtained BAL fluid by flushing the airways three times with
a single use of 1 mL sterile PBS via a trachea incision. BAL fluid
cytokine content was determined via ELISA (BD Biosciences)
according to the manufacturer manual. Viral titer was determined
via endpoint dilution assay and expressed as tissue culture
infectious dose 50 (TCID50) units. We incubated Madin-Darby
canine kidney cells (ATCC collection) with tenfold dilutions of
BAL fluid from influenza virus-infected mice in serum-free
DMEM culture+trypsin. After 3–4 day incubation at 37uC in a
humidified atmosphere of 5% CO2, supernatants were collected
and mixed with a half-volume of 1% chicken red blood cells
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(University of Virginia Veterinary Facilities). Hemagglutinin
patterns were read thereafter and calculated as TCID50 values.
Real-Time PCR
RNA from sorted cells was isolated as previously described [19].
We performed real-time RT-PCR in a StepOnePlue PCR System
(Applied Biosystems) with SYBR Green PCR Master Mix (Applied
Biosystems). Data were generated by the comparative threshold
cycle DCTð Þ method by normalizing to GAPDH. The sequences
of GAPDH primers used in the studies are available on request.
Forward and reverse primers amplifying M2 vmRNA are as
follows, respectively: 59 – GAGGTCGAAACG CCT – 39 and 59 –
CTGTTCCTTTCGATATTCTTCCC – 39
Neutrophil depletion
At noted day after infection with influenza, we injected mice
with 500 mg Ly6G-specific mAb (clone IA8, BioExpress) or
isotype, i.p..
In vivo intracellular cytokine staining assay
Cytokine-producing cells in vivo were measured utilizing
monensin on a previously described protocol [5].
Statistics
An un-paired two-tailed T test was used to compare between
treatment groups. Statistical analyses were performed using
Prism3 software (for Macintosh; GraphPad Software, Inc.). Results
are expressed as means 6 SEM unless noted otherwise. Values of
P,0.05 were considered statistically significant.
Supporting Information
Figure S1 Identification of neutrophils and inflamma-
tory mononuclear cells in the infected lung. Representative
flow cytometry panels of the lung suspension collected from a day
four post infected BALB/c mouse (A/PR/8/34; LD50= 0.1).
Neutrophils (A) were identified as CD45+Ly6G+CD11bhiLy6Cint.
The cell type has the characteristic FSC/SSC profile of
neutrophils. Inflammatory mononuclear cells (B) are a heteroge-
nous immune infiltrate identified as CD45+Ly6G2CD11bhiLy6-
ChiCD11chi.
(TIF)
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